Tretinoin microsphere gel in younger acne patients

Journal of Drugs in Dermatology

Volumn 7, Issue 8, 2008, Pages

  Jorizzo, Joseph ^a   Grossman, Rachel ^b   Nighland, Marge ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b JOHNSON AND JOHNSON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KERATOLYTIC AGENT; MICROSPHERE; RETINOIC ACID;

ACNE VULGARIS; ADOLESCENT; ADULT; ARTICLE; GEL; HUMAN; RANDOMIZED CONTROLLED TRIAL;

ACNE VULGARIS; ADOLESCENT; ADULT; GELS; HUMANS; KERATOLYTIC AGENTS; MICROSPHERES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TRETINOIN;

EID: 58149134472     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Rademaker M, Garioch JJ, Simpson NB. Acne in schoolchildren: no longer a concern for dermatologists. BMJ. 1989;298:1217-1219. (Pubitemid 19122792)
2. Lello J, Pearl A, Arroll B, et al. Prevalence of acne vulgaris in Auckland senior high school students. N Z Med J. 1995;108:287-289.
3. Smithard A, Glazebrook C, Williams HC. Acne prevalence, knowledge about acne and psychological morbidity in mid-adolescence: a community-based study. Br J Dermatol. 2001;145:274-279. (Pubitemid 32955354)
4. Krowchuk DP, Stancin T, Keskinen R, et al. The psychosocial effects of acne on adolescents. Pediatr Dermatol. 1991;8:332-338.
5. Aktan S, Ozmen E, Sanli B. Anxiety, depression, and nature of acne vulgaris in adolescents. Int J Dermatol. 2000;39:354-357. (Pubitemid 30335781)
6. Berson DS, Chalker DK, Harper JC, et al. Current concepts in the treatment of acne: report from a clinical roundtable. Cutis. 2003; 72 (Suppl):5-13.
7. Feldman S, Careccia RE, Barham KL, Hancox J. Diagnosis and treatment of acne. Am Fam Physician. 2004;69:2123-2130.
8. Goulden V. Guidelines for the management of acne vulgaris in adolescents. Paediatr Drugs. 2003;5:301-313. (Pubitemid 36629713)
9. Krowchuk DP. Managing acne in adolescents. Pediatr Clin North Am. 2000;47:841-857. (Pubitemid 30480392)
10. Akhavan A, Bershad S. Topical acne drugs: review of clinical properties, systemic exposure, and safety. Am J Clin Dermatol. 2003;4: 473-492. (Pubitemid 36871766)
11. Chivot M. Retinoid therapy for acne. A comparative review. Am J Clin Dermatol. 2005;6:13-19. (Pubitemid 40289257)
12. Webster GF. Topical tretinoin in acne therapy. J Am Acad Dermatol. 1998;39:S38-S44. (Pubitemid 28367285)
13. Webster G. Mechanism-based treatment of acne vulgaris: the value of combination therapy. J Drugs Dermatol. 2005;4:281-288.
14. Embil K, Nacht S. The Microsponge Delivery System (MDS): a topical delivery system with reduced irritancy incorporating multiple triggering mechanisms for the release of actives. J Microencapsul. 1996;13:575-588. (Pubitemid 26283810)
15. Galvin SA, Gilbert R, Baker M, et al. Comparative tolerance of adapalene 0.1% gel and six different tretinoin formulations. Br J Dermatol. 1998;139 (Suppl):34-40.
16. Grove GL, Zerweck CR, Nacht S, Leyden JL. The effect of vehicle composition on the subjective and objective irritancy potency of retinoic acid formulations. Poster presented at: American Academy of Dermatology Meeting; March 1997; San Francisco, Calif.
17. Offi ce of the Federal Register. Code of Federal Regulations. Adequate and well-controlled studies. Title 21: Food and Drugs, Part 314.126. Washington, DC: US Government Printing Office, 1997.
18. Burke BM, Cunliffe WJ. The assessment of acne vulgaris-the Leeds technique. Br J Dermatol. 1984;111:83-92. (Pubitemid 14086231)
19. Nyirady J, Nighland M, Payonk G, et al. A comparative evaluation of tretinoin gel microsphere, 0.1%, versus tretinoin cream, 0.025%, in reducing facial shine. Cutis. 2000;66:153-156.
20. Bershad S. Developments in topical retinoid therapy for acne. Semin Cutan Med Surg. 2001;20:154-161. (Pubitemid 32927777)
21. Shalita AR, Rafal ES, Anderson DN, et al. Compared efficacy and safety of tretinoin 0.1% microsphere gel alone and in combination with benzoyl peroxide 6% cleanser for the treatment of acne vulgaris. Cutis. 2003;72:167-172. (Pubitemid 37229749)
22. Waugh J, Noble S, Scott LJ. Adapalene: a review of its use in the treatment of acne vulgaris. Drugs. 2004;64:1465-1478. (Pubitemid 38980458)
23. Nyirady J, Grossman RM, Nighland M, et al. A comparative trial of two retinoids commonly used in the treatment of acne vulgaris. J Dermatolog Treat. 2001;12:149-157. (Pubitemid 33116877)
24. Dosik JS, Homer K, Arsonnaud S. Cumulative irritation potential of adapalene 0.1% cream and gel compared with tretinoin microsphere 0.04% and 0.1%. Cutis. 2005;75:238-243. (Pubitemid 40627632)
25. Greenspan A, Loesche C, Vendetti N, et al. Cumulative irritation comparison of adapalene gel and solution with 2 tazarotene gels and 3 tretinoin formulations. Cutis. 2003;72:76-81. (Pubitemid 37229762)
26. Egan N, Loesche MC, Baker MM. Randomized, controlled, bilateral (split-face) comparison trial of the tolerability and patient preference of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris. Cutis. 2001;68 (Suppl):20-24.
27. Thiboutot D, Gold MH, Jarratt MT, et al. Randomized controlled trial of the tolerability, safety, and effi cacy of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris. Cutis. 2001;68 (Suppl):10-19.
28. Brand B, Gilbert R, Baker MD, et al. Cumulative irritancy comparison of adapalene gel 0.1% versus other retinoid products when applied in combination with topical antimicrobial agents. J Am Acad Dermatol. 2003;49:S227-S232. (Pubitemid 37046537)